跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Naprox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Naprox
Approved
STANDARD
Naprox
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
71ebb1149f5a0cf6
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
71ebb1149f5a0cf6
Drug Approval Philippines Name
Naprox
Product Name
Naprox
Registration Number
DRP-4900
Brand Name
Naprox
Generic Name
Naproxen Sodium
Dosage Form
Tablet
Dosage Strength
550 mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Issuance Date
25 January 2024
Expiry Date
07 November 2028
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
71ebb1149f5a0cf6
Type
Standard
Back to Philippines FDA Approvals